Amgen Looks To U.S. Contracting Strategies To Head Off European Biosimilars

Amgen is bringing U.S. contracting strategies to Europe as part of its efforts to stave off competition from biosimilars, Exec VP-Commercial Operations George Morrow said during the firm's recent annual business review